Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tempus AI

61.37
-3.8500-5.90%
Post-market: 61.08-0.2892-0.47%19:59 EDT
Volume:15.52M
Turnover:977.93M
Market Cap:10.62B
PE:-12.47
High:66.30
Open:66.26
Low:60.50
Close:65.22
Loading ...

Tempus to Participate in the Morgan Stanley Technology, Media and Telecom Conference

Business Wire
·
18 Feb

Insiders Dump Tempus AI (NASDAQ:TEM) Stock as Shares Notch Fresh Record Highs

TIPRANKS
·
17 Feb

Why Tempus AI, Inc. (TEM) Soared Last Week

Insider Monkey
·
17 Feb

Tempus AI, Inc. Class A (TEM) was downgraded to a Hold Rating at William Blair

TIPRANKS
·
15 Feb

T-Mobile Hits Record High, Joins Big Cap 20: Check Out New Names On IBD 50, Stock Spotlight And More

Blockhead
·
15 Feb

Tempus AI, Inc. (TEM): Among the Health Information Services Stocks Outpacing the Market in 2025

Insider Monkey
·
15 Feb

Medical AI Stocks Soar; CRISPR Rises 16%; Recursion Pharma Jumps 14%; Tempus AI up 5%

Tiger Newspress
·
14 Feb

U.S. Stocks to Watch: Airbnb, Roku, Tempus AI, Twilio, Intel, DraftKings, Palo Alto, GameStop, and More

Dow Jones
·
14 Feb

Tempus AI Stock (TEM) Hits New 52-Week despite Analyst Downgrade

TIPRANKS
·
14 Feb

Why Tempus AI Inc. (TEM) Went Up on Thursday

Insider Monkey
·
14 Feb

tempus AI Inc Class A call volume above normal and directionally bullish

TIPRANKS
·
13 Feb

Medical AI Stocks Soar; Firefly Neuroscience Rises 19%; Tempus AI Jumps 6% After Rising 130% This Year

Tiger Newspress
·
13 Feb

Stock Track | Tempus AI Soars Nearly 8% as Expansion Moves and Strong Growth Projections Fuel Rally

Stock Track
·
13 Feb

William Blair Downgrades Tempus AI, Inc. (TEM) to Market Perform on Valuation Concerns

Insider Monkey
·
13 Feb

Stock Track | Tempus AI Soars 5% in Pre-Market on Acquisition and Growth Prospects

Stock Track
·
13 Feb

Tempus Announces Collaboration With Ifli Aimed at Supporting Development of Targeted Therapies for Follicular Lymphoma

THOMSON REUTERS
·
13 Feb

Tempus Announces Collaboration with IFLI Aimed at Supporting Development of Targeted Therapies for Follicular Lymphoma

Business Wire
·
13 Feb

Tempus AI, Inc. (TEM): Among the Large-Cap Stocks Insiders Are Selling Recently

Insider Monkey
·
13 Feb

AI Stocks Shine. Confluent up 20%; BigBear.ai up 13%; Tempus AI, Palantir Jump 2%

Tiger Newspress
·
12 Feb

Stock Track | Tempus AI Plunges 5.15% in Pre-Market on Analyst Downgrade Citing Valuation Concerns

Stock Track
·
12 Feb